Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aladdin Healthcare Technologies SE is an AI-driven healthcare company specializing in drug discovery and diagnostics for age-related diseases, particularly Alzheimer's and Parkinson's. The company utilizes its proprietary AI platform, including the PharmaKG biomedical knowledge graph, to identify novel small molecule drug candidates and biomarkers. Based in Berlin and London, Aladdin collaborates with leading academic institutions and partners like No-Age Biotech to accelerate the development of precision medicines and early diagnostic tools. The company's pipeline includes AI-assisted programs for neurodegenerative diseases and a diagnostic prototype for pulmonary conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aladdmin.